C

Changchun High & New Technology Industries Group Inc
SZSE:000661

Watchlist Manager
Changchun High & New Technology Industries Group Inc
SZSE:000661
Watchlist
Price: 109.6 CNY -3.02% Market Closed
Market Cap: 44.4B CNY
Have any thoughts about
Changchun High & New Technology Industries Group Inc?
Write Note

Changchun High & New Technology Industries Group Inc
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Changchun High & New Technology Industries Group Inc
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
C
Changchun High & New Technology Industries Group Inc
SZSE:000661
Long-Term Investments
ÂĄ1.3B
CAGR 3-Years
2%
CAGR 5-Years
15%
CAGR 10-Years
32%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Long-Term Investments
ÂĄ684.7m
CAGR 3-Years
189%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Long-Term Investments
ÂĄ571.9m
CAGR 3-Years
-14%
CAGR 5-Years
-11%
CAGR 10-Years
1%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Long-Term Investments
ÂĄ1.5B
CAGR 3-Years
-10%
CAGR 5-Years
53%
CAGR 10-Years
77%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Long-Term Investments
ÂĄ12.7B
CAGR 3-Years
120%
CAGR 5-Years
31%
CAGR 10-Years
68%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Long-Term Investments
ÂĄ1.6m
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Changchun High & New Technology Industries Group Inc
Glance View

Market Cap
44.3B CNY
Industry
Pharmaceuticals

Changchun High & New Technology Industries (Group), Inc. engages in the research, development, production, and sale of biopharmaceuticals and proprietary Chinese medicines. The company is headquartered in Changchun, Jilin and currently employs 8,045 full-time employees. The Company’s main products include polyethylene glycol recombinant human growth hormone injection, recombinant human growth hormone, recombinant human follicle stimulating hormone for injection, freeze-dried live attenuated varicella vaccines and rabies vaccines for human use, among other. The firm is also involved in real estate development and property management businesses. The firm operates its business mainly in domestic market.

Intrinsic Value
186.04 CNY
Undervaluation 41%
Intrinsic Value
Price
C

See Also

What is Changchun High & New Technology Industries Group Inc's Long-Term Investments?
Long-Term Investments
1.3B CNY

Based on the financial report for Sep 30, 2024, Changchun High & New Technology Industries Group Inc's Long-Term Investments amounts to 1.3B CNY.

What is Changchun High & New Technology Industries Group Inc's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
32%

Over the last year, the Long-Term Investments growth was -3%. The average annual Long-Term Investments growth rates for Changchun High & New Technology Industries Group Inc have been 2% over the past three years , 15% over the past five years , and 32% over the past ten years .

Back to Top